Johnson & Johnson is an American multinational medical devices,
pharmaceutical and consumer packaged goods manufacturer founded in 1886.
Its common stock is a component of the Dow Jones Industri...
Mar 29, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry
its use in women will be somewhat minimal,” Butler said.
Apr 21, 2014 ... Johnson's Invokana is about to face a host of new SGLT2 ... Express Scripts
expects spending on diabetes treatment will grow 11% in ... AstraZeneca (NYSE:
AZN) won FDA approval for its SGLT2 drug, Farxiga, in January.
Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ...
As the first company to win FDA approval, Johnson & Johnson has a leg up on
industry rivals developing their own ... More details on the studies will be
presented at the American Diabetes Association annual meeting in June.
Mar 29, 2013 ... Some analysts think doctors will use the SGLT class as a last-line option behind
other ... The FDA's approval of Invokana is a milestone for J&J because, although
the ... as blood-glucose meters, Invokana is its first prescription drug for type 2
diabetes. ... Tour de France 2016: Chris Froome Wins Third Title.
Mar 30, 2013 ... The drug, Invokana, will be sold by Johnson & Johnson and treats patients with
type 2 diabetes in a new way, by causing blood sugar to be ...
May 20, 2015 ... J&J has a lofty goal of churning out new blockbusters from its Janssen pharma
unit, ... new drugs and 40 line extensions for regulatory approval by 2019. ... that
it is exploring safety concerns regarding diabetes drugs that are in a .... the robot
that won Jeopardy—to create a concierge service that will prepare ...
Janssen won approval from the FDA for Invokamet, a fixed-dose combination of
... Johnson & Johnson received federal approval for its diabetes drug Invokamet.
Mar 29, 2013 ... FDA has approved a new diabetes drug from Johnson & Johnson, making it the
first in its class to be approved in the United States. The U.S. ...
Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly
half of ... Janssen will partner with other Johnson & Johnson companies focused
on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.